Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulants and Bleeding Disorders”

226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 226 results

Not applicableLooking for participantsNCT06696079
What this trial is testing

Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation

Who this might be right for
Chronic Subdural HematomaAtrial Fibrillation (AF)
Rahul Raj 332
Testing effectiveness (Phase 2)Study completedNCT03212365
What this trial is testing

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolus+1 more
University of Utah 295
Post-approval studies (Phase 4)UnknownNCT02666157
What this trial is testing

Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
National Cheng-Kung University Hospital 3,672
Not applicableUnknownNCT03124030
What this trial is testing

Intra- and Post- Operative Bleeding After Simple Dental Extraction in Direct Oral Anticoagulant Therapy

Who this might be right for
Anticoagulant-induced BleedingDental Diseases
University of Trieste 128
Not applicableStudy completedNCT02468102
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Who this might be right for
Acute Coronary SyndromeVenous ThrombosisPulmonary Embolism+1 more
Bayer 99,999
Not applicableStudy completedNCT03803579
What this trial is testing

Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)

Who this might be right for
Atrial FibrillationAnticoagulant-induced Bleeding
Arianna Anticoagulazione Foundation 2,000
Not applicableStudy completedNCT03871283
What this trial is testing

Anticoagulation and Antiplatelet Management During Perioperative Period

Who this might be right for
Anticoagulants and Bleeding Disorders
Erasme University Hospital 2,400
Not applicableStudy completedNCT05422157
What this trial is testing

Evaluation of the Inter-center Variability of the Measurement of Thrombin Generation by the ST Genesia System

Who this might be right for
Patients Without a Medical History of Thrombosis or HemorrhageHemophilic PatientPatient With FV Leiden Mutation+2 more
University Hospital, Clermont-Ferrand 71
Post-approval studies (Phase 4)Not Yet RecruitingNCT06452342
What this trial is testing

TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study

Who this might be right for
Venous ThromboembolismVenous ThrombosesHeavy Menstrual Bleeding+1 more
University Health Network, Toronto 20
Early research (Phase 1)Study completedNCT06517563
What this trial is testing

Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin

Who this might be right for
Coagulation Disorder
VarmX B.V. 16
Not applicableLooking for participantsNCT07083609
What this trial is testing

Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam

Who this might be right for
Cerebral Venous Thrombosis
Hieu Trung Dinh 69
Post-approval studies (Phase 4)Looking for participantsNCT04263038
What this trial is testing

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Who this might be right for
Pulmonary EmbolismEmbolismEmbolism and Thrombosis+6 more
Drahomir Aujesky 276
Not applicableLooking for participantsNCT06957366
What this trial is testing

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

Who this might be right for
Atrial Fibrillation (AF)VTE
McMaster University 920
Not applicableStudy completedNCT04068727
What this trial is testing

LEAVE Safe With DOACs

Who this might be right for
Cardiovascular DiseasesVenous ThromboembolismAtrial Fibrillation+2 more
University of Massachusetts, Worcester 561
Not applicableWithdrawnNCT03399305
What this trial is testing

Safety and Efficacy of Apixaban in Severe Renal Impairment

Who this might be right for
Renal Disease, End StageAnticoagulant-induced Bleeding
Albert Einstein College of Medicine
Large-scale testing (Phase 3)Study completedNCT03181386
What this trial is testing

Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants

Who this might be right for
Atrial FibrillationPeriodontal DiseaseHemorrhage
University of Sao Paulo General Hospital 60
Not applicableNot Yet RecruitingNCT07173075
What this trial is testing

Evaluation of the Relationship Between Muscle Mass Measured by Bioelectrical Impedance Analysis and the Risk of Hemorrhagic Events Under Direct Oral Anticoagulants in the Elderly

Who this might be right for
Direct Oral AnticoagulantHemmorhageElderly+3 more
University Hospital, Clermont-Ferrand 110
Not applicableNot Yet RecruitingNCT06582563
What this trial is testing

Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants

Who this might be right for
Blood Coagulation Disorder
Perosphere Technologies Inc. 120
Not applicableStudy completedNCT03093233
What this trial is testing

Multicenter Analysis of Oral Anticoagulant-associated ICH - Part Two

Who this might be right for
Anticoagulation Associated (VKA & NOAC) Intracerebral Hemorrhage
University of Erlangen-Nürnberg Medical School 1,369
Post-approval studies (Phase 4)Looking for participantsNCT04436978
What this trial is testing

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionAtrial Fibrillation+8 more
St. Antonius Hospital 2,000
Load More Results